Quality is our legacy     
.
Site Language
.
.

.
 Search 
   Home
 
SEDICO Company
About SEDICO
News and Reports
Worldwide Presence
Careers at SEDICO
 
SEDICO products
Products List
Strategic Brands
Search for a product
 
Social Contribution
Diabetes Center
R&D
Caring for community
Access for medicines
 
Contact SEDICO
Contact Us
Distributors Log in
Partners Log in
Vendors Log in
Physicians Log in
Patients Log in
 
SEDICO Newsletter
Subscribe to SEDICO News

   Enter Your E-mail
 

Physician
Patient

INSULIN H BIO NPH    

(Recombinant Human Insulin with Protamine sulphate)
40 IU or 100 IU / ml suspension. 10ml

Human Insulin Production in Egypt, Insulin NPH 40 IU  Human Insulin Production in Egypt, Insulin NPH 100 IU
Human Insulin Production in Egypt


Composition:
Each 1 ml contains recombinant human insulin 40 or 100 IU, Protamine sulphate metacresol, glycerol, phenol crystalline, sodium phosphate dihydrate, and water for the injection


Indications:
‎Diabetes mellitus type I :( insulin dependent) found in children and adults.
‎Diabetes mellitus type II :( non insulin dependent) at the stage of resistance of per-oral hypoglycemic drugs, particular resistance to drugs (combined therapy), undercurrent diseases, surgical operations (mono or combined),& diabetes type II in pregnant women.


Dosage:
The dosage and route of administration is defined individually in each case.
‎The drug is administered subcutaneously 1-2 times per day.
‎Roll the vial carefully between the palms of the hands before use.
‎If the daily dose exceeds 0.6 IU / Kg, insulin Hbio NPH is injected two times daily into different parts of the body.


Presentation:
Box of 10 ml vial of recombinant Human insulin with Protamine sulphate 40 or 100 IU / ml suspension.


© 2004 Sedico Co. All rights reserved
Designed and Developed by EBM Co.